Your browser doesn't support javascript.
loading
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001.
Vrooman, Lynda M; Blonquist, Traci M; Stevenson, Kristen E; Supko, Jeffrey G; Hunt, Sarah K; Cronholm, Sarah M; Koch, Victoria; Kay-Green, Samantha; Athale, Uma H; Clavell, Luis A; Cole, Peter D; Harris, Marian H; Kelly, Kara M; Laverdiere, Caroline; Leclerc, Jean-Marie; Michon, Bruno; Place, Andrew E; Schorin, Marshall A; Welch, Jennifer J G; Neuberg, Donna S; Sallan, Stephen E; Silverman, Lewis B.
Afiliación
  • Vrooman LM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Blonquist TM; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School Boston, MA.
  • Stevenson KE; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Supko JG; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
  • Hunt SK; Department of Medicine, Massachusetts General Hospital, Boston, MA.
  • Cronholm SM; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Koch V; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Kay-Green S; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Athale UH; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Clavell LA; Division of Pediatric Hematology/Oncology, McMaster University, Hamilton, ON, Canada.
  • Cole PD; Division of Pediatric Oncology, San Jorge Children's Hospital, San Juan, Puerto Rico.
  • Harris MH; Division of Pediatric Hematology/Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ.
  • Kelly KM; Department of Pathology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Laverdiere C; Department of Pediatric Oncology, Roswell Park Cancer Institute and Oishei Children's Hospital, University at Buffalo School of Medicine and Biomedical Sciences, Buffalo, NY.
  • Leclerc JM; Division of Hematology and Oncology, Hospital Sainte-Justine, University of Montreal, Montreal, Canada.
  • Michon B; Division of Hematology and Oncology, Hospital Sainte-Justine, University of Montreal, Montreal, Canada.
  • Place AE; Division of Hematology-Oncology, Centre Hospitalier Universite de Quebec, Quebec City, Canada.
  • Schorin MA; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Welch JJG; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School Boston, MA.
  • Neuberg DS; Inova Fairfax Hospital for Children, Falls Church, VA.
  • Sallan SE; Division of Pediatric Hematology/Oncology, Hasbro Children's Hospital, Brown University Medical School, Providence, RI.
  • Silverman LB; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.
J Clin Oncol ; 39(31): 3496-3505, 2021 11 01.
Article en En | MEDLINE | ID: mdl-34228505
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: America do norte Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Marruecos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Child / Child, preschool / Female / Humans / Infant / Male País/Región como asunto: America do norte Idioma: En Revista: J Clin Oncol Año: 2021 Tipo del documento: Article País de afiliación: Marruecos